Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




No Screening for Bladder Cancer: Insufficient EvidenceNo Screening for Bladder Cancer: Insufficient
Link ID 37238
Title No Screening for Bladder Cancer: Insufficient EvidenceNo Screening for Bladder Cancer: Insufficient
Url http://www.medscape.com/viewarticle/748013?src=rsshttp://www.medscape.com/viewarticle/748013?src=rss
Description The tests that are currently available, mainly focused on measuring blood in the urine, have a low positive predictive value. br / iMedscape Medical News/i
Category Articles > Hematology-Oncology
Keywords
Date Aug 16, 2011
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Long-Term Results Support Hypofractionated Whole-Breast Irradiation
  Researchers are encouraging broader use of hypofractionated irradiation in early breast cancer. Medscape Medical News
Category:   Articles > Hematology-Oncology


2. A Surprise: Chemoprotective Agent May Improve Survival in NSCLC
  Dimensa was originally a chemoprotective agent, but is now being studied as an anticancer agent in a phase 3 clinical trial. Medscape Medical News
Category:   Articles > Hematology-Oncology


3. Lasofoxifene Could Be Tipping Point for Breast Cancer Chemoprevention
  Tamoxifen and raloxifene have not been widely embraced for chemoprevention in breast cancer, but the results of a major clinical trial provide new hope for another agent. Medscape Medical News
Category:   Articles > Hematology-Oncology


4. Novel Targeted Drug Therapies for the Treatment of Childhood Acute Leukemia
  Pharmacologic agents that are showing promise in the treatment of childhood acute leukemia, including monoclonal antibodies, kinase and protease inhibitors, and more are reviewed in this article. Expert Review of Hematology
Category:   Articles > Hematology-Oncology


5. New Treatment for Pediatric Hodgkin Lymphoma Patients Reduces Long-Term Effects
  A "dose-dense" chemotherapy provides high efficacy and excellent outcomes and reduces the cumulative doses of chemotherapy and radiation below thresholds usually associated with long-term toxicity. Medscape Medical News
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS